The study drug abc294640 is an orally available inhibitor of the enzyme sphingosine kinase 2 sk2.
Bile duct cancer cure clinical trials.
Clinical trials are research studies that involve people.
Clinical trials are used for all types and stages of bile duct cancer.
Nci s basic information about clinical trials explains the types and phases of trials and how they are carried out.
Clinical trials look at new ways to prevent detect or treat disease.
These types of studies evaluate new drugs different combinations of existing treatments new approaches to radiation therapy or surgery and new methods of treatment.
Many focus on new treatments to learn if a new treatment is safe effective and possibly better than the existing treatments.
All trials on the list are supported by nci.
It explores whether a targeted therapy called ramucirumab can help control bile duct cancer.
Abc 108 is a single arm phase iia clinical study of abc294640 yeliva in the treatment of cholangiocarcinoma cca.
When the cancer started growing again she suggested i consider a new clinical trial.